What is the British Pharmacopoeia and why should my organisation use it?
Various access options are available to suit your company’s size and needs, including:
The British Pharmacopoeia (BP) provides you with the official standards for making pharmaceuticals to sell in the UK or Europe.
The BP makes an important contribution to the role of the Medicines and Healthcare products Regulatory Agency (MHRA) in protecting public health and is used in 100 countries by individuals and organisations involved in pharmaceutical research, development, manufacture, quality control and analysis.
The BP is also:
Our online formats are the best way to ensure products comply with legal standards, with digital features to help you get more done quickly, easily and with confidence.
You can also, through your online login:
- Add the BP Archive option to your standard package to see what's changed more clearly from previous editions.
- Add the British Approved Names (BAN) 2022 to quickly reference adopted medicinal substance names.
Online access for one user (Single User Licence, SUL) from £875
Online access for two or more users
(Multi User Licence, MUL)
from £2,400
Online Tools and Features
- NEW Revision History (beta) - Quickly find and understand the significance of changes to a monograph so you can better assess the impact to your work.
- Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.
- Streamlined Timeline functionality helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and European Pharmacopoeia (Ph. Eur.), through the improved navigation.
- Concise 'How to use the BP' guide helps you to comply with the BP, navigate more effectively and follow formulated product monographs.
- Updates to BPCRS to coincide with each new BP edition.
- New Revision History beta allows website users to easily view and understand the reasons a change to a monograph has been made.
- Over 4,000 monographs, including all monographs and texts from the European Pharmacopoeia.